Literature DB >> 13794464

The continuous alternating chemotherapy of cancer.

M ARONOVITCH.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy

Mesh：

Substances：

Year:  1960        PMID： 13794464      PMCID： PMC1938383     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  10 in total

1.  [Clinical experience report of a new cytostatic (endoxan); preliminary report].

Authors:  H SAITMACHER
Journal:  Strahlentherapie       Date:  1958-09

2.  The chemotherapeutic effects and complications of actinomycin D in patients with advanced cancer.

Authors:  G E MOORE; J A DIPAOLO; T KONDO
Journal:  Cancer       Date:  1958 Nov-Dec       Impact factor: 6.860

3.  Treatment of hepatic coma with L-glutamic acid.

Authors:  W V MCDERMOTT; J WAREHAM; A G RIDDELL
Journal:  N Engl J Med       Date:  1955-12-22       Impact factor: 91.245

4.  Treatment of chronic granulocytic leukemia with myleran.

Authors:  A UNUGUR; E SCHULMAN; W DAMESHEK
Journal:  N Engl J Med       Date:  1957-04-18       Impact factor: 91.245

5.  Clinical studies with 5-fluorouracil.

Authors:  A R CURRERI; F J ANSFIELD; F A McIVER; H A WAISMAN; C HEIDELBERGER
Journal:  Cancer Res       Date:  1958-05       Impact factor: 12.701

6.  Multiple remissions in an adult with acute leukemia treated principally with a-methopterin.

Authors:  R L ENGLE; E F HAYS; T C SCANLAN
Journal:  Ann Intern Med       Date:  1956-08       Impact factor: 25.391

7.  Hormones and radioactivity in cancer therapy.

Authors:  F T BRAYER; S R GLASSER; J W HOWLAND
Journal:  N Y State J Med       Date:  1956-03-15

8.  Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in the treatment of leukemia and allied diseases.

Authors:  J H BURCHENAL; M L MURPHY; R R ELLISON; M P SYKES; T C TAN; L A LEONE; D A KARNOFSKY; L F CRAVER; H W DARGEON; C P RHOADS
Journal:  Blood       Date:  1953-11       Impact factor: 22.113

9.  The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides.

Authors:  A Gilman; F S Philips
Journal:  Science       Date:  1946-04-05       Impact factor: 47.728

10.  Quantitative biochemical differences between tumor and host as a basis for cancer chemotherapy. V. Niacin and 6-aminonicotinamide.

Authors:  D M SHAPIRO; L S DIETRICH; M E SHILS
Journal:  Cancer Res       Date:  1957-07       Impact factor: 12.701
  10 in total
  2 in total

1.  Use of cyclophosphamide in advanced malignancies.

Authors:  M ARONOVITCH; J F MEAKINS; M GROSZMAN
Journal:  Can Med Assoc J       Date:  1960-11-05       Impact factor: 8.262

2.  SOME PROBLEMS IN THE CHEMOTHERAPY OF SOLID TUMOURS.

Authors:  M ARONOVITCH; M GROSZMAN; L M KAHANA
Journal:  Can Med Assoc J       Date:  1964-03-14       Impact factor: 8.262
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.